Musclepharm (MSLP) Gross Profit Margin starting from the first quarter 2022 to first quarter 2021, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Musclepharm Corporation  (MSLP)


Musclepharm's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MSLP Gross Profit Margin (Mar 31 2022)
Q1 		(Dec 31 2021)
Q4 		(Sep 30 2021)
Q3 		(Jun 30 2021)
Q2 		(Mar 31 2021)
Q1
Y / Y Revenue Change -0.15 %
Seq. Revenue Change 30.46 %
Revenue In Millions $13.10
Gross Profit Margin 11.52 %
Gross Profit Margin Total Ranking # 3715
Gross Profit In Millions $1.51
Y / Y Gross Profit Change -59.09 %
Seq. Gross Profit Change -


Commenting First Quarter 2022 Gross Profit Margin
Musclepharm Corporation achieved Gross Profit of $2 millions compare to Gross Loss of $-0.53 millions recorded in the previous quarter. Revenue increased by 30.46 % Company accomplished below the average Gross Profit Margin with 11.52 %.


Observing first quarter 2022 results within Major Pharmaceutical Preparations industry 180 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 3715.
Learn about Gross Margin
MSLP's Gross Profit Margin first quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 181
Healthcare Sector # 539
Overall # 3642

Gross Profit Margin Statistics
High Average Low
40.09 % 26.58 % 0.24 %
(Sep 30 2018)   (Sep 30 2021)


MSLP Gross Income Trends • More of MSLP's Profitabilty Ratios • MSLP Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
MSLP's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
MSLP's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for MSLP's Competitors
Gross Profit Margin Profit Margin for Musclepharm's Suppliers
Gross Profit Margin Profit Margin for MSLP's Customers

You may also want to know
MSLP's Annual Growth Rates MSLP's Profitability Ratios MSLP's Asset Turnover Ratio MSLP's Dividend Growth
MSLP's Roe MSLP's Valuation Ratios MSLP's Financial Strength Ratios MSLP's Gross Profit Growth
MSLP's Roa MSLP's Inventory Turnover Ratio MSLP's Growth Rates MSLP's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2022, within Major Pharmaceutical Preparations Industry Gross Profit MarginMar 31 2022 MRQ Gross ProfitMar 31 2022 MRQ Revenue
Perrigo Company Plc  31.46 %$ 337.800  Millions$ 1,073.800  Millions
Phibro Animal Health Corporation  29.89 %$ 71.626  Millions$ 239.619  Millions
Mannkind Corporation  27.33 %$ 3.278  Millions$ 11.992  Millions
Cv Sciences Inc   26.00 %$ 1.156  Millions$ 4.447  Millions
Societal Cdmo Inc   23.97 %$ 5.080  Millions$ 21.194  Millions
Avid Bioservices Inc   22.37 %$ 6.984  Millions$ 31.226  Millions
Athenex Inc   21.63 %$ 6.429  Millions$ 29.724  Millions
Aclaris Therapeutics Inc   20.51 %$ 0.298  Millions$ 1.453  Millions
Sunwin Stevia International Inc.  19.13 %$ 1.509  Millions$ 7.887  Millions
Chembio Diagnostics Inc   19.09 %$ 3.593  Millions$ 18.817  Millions
Vireo Growth Inc.  15.91 %$ 2.489  Millions$ 15.639  Millions
Agile Therapeutics Inc  13.29 %$ 0.234  Millions$ 1.761  Millions
Integrated Biopharma Inc  12.68 %$ 1.982  Millions$ 15.634  Millions
Theralink Technologies Inc   11.90 %$ 0.002  Millions$ 0.020  Millions
Musclepharm Corporation  11.52 %$ 1.509  Millions$ 13.101  Millions
Aditxt Inc   10.56 %$ 0.022  Millions$ 0.210  Millions
Blueprint Medicines Corporation  9.68 %$ 6.115  Millions$ 63.173  Millions
American Bio Medica Corporation  7.98 %$ 0.028  Millions$ 0.351  Millions
Pasithea Therapeutics Corp   5.28 %$ 0.001  Millions$ 0.014  Millions
Lannett Company Inc  3.93 %$ 3.078  Millions$ 78.357  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.